Cell Therapy Clinical Trials

1 actively recruiting trial across 1 location

Filter by location:

Chapel Hill, North Carolina1 trial

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.